Yasunori Kaneko - Feb 27, 2025 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role: Director
Signature: /s/ Carolyn Tang, Attorney-in-Fact
Stock symbol: RCUS
Transactions as of: Feb 27, 2025
Transactions value $: $201,200
Form type: 4
Date filed: 2/27/2025, 07:06 PM
Previous filing: Jun 7, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCUS	Common Stock	Purchase	$201K	+20K	+238.1%	$10.06	28.4K	Feb 27, 2025	Direct	F1
holding	RCUS	Common Stock						253K	Feb 27, 2025	By Kaneko Investments, LLC
holding	RCUS	Common Stock						153K	Feb 27, 2025	By Trust	F2
holding	RCUS	Common Stock						505K	Feb 27, 2025	By Kaneko Capital, LLC

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	Includes 6,800 shares of restricted stock units (previously reported) that vested on June 6, 2024 and were subsequently transferred to the reporting person's trust.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Includes 6,800 shares of restricted stock units (previously reported) that vested on June 6, 2024 and were subsequently transferred to the reporting person's trust.